Published Online
on June 29, 2006

A more recent version of this article appeared on August 1, 2006

This Article Full Text (PDF) All Versions of this Article: 37/8/2189    most recent 01.STR.0000230598.31774.7av1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Papadakis, M. Articles by Buchan, A. M. Search for Related Content PubMed PubMed Citation Articles by Papadakis, M. Articles by Buchan, A. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Antioxidants Stroke Related Collections Other Stroke

Submitted on April 19, 2006
Accepted on May 1, 2006

NXY-059. Brain or Vessel Protection

Michalis Papadakis PhD and Alastair M. Buchan MD, FRCPC^*

From the Acute Stroke Programme, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom (M.P., A.M.B.); and the Henry Wellcome Building for Molecular Physiology, Oxford, United Kingdom (M.P.).

^* To whom correspondence should be addressed. E-mail: alastair.buchan{at}ndm.ox.ac.uk.

Key words: neuroprotectants

This article has been cited by other articles:

				M. S. Hussain and A. Shuaib Research Into Neuroprotection Must Continue ... but With a Different Approach Stroke, February 1, 2008; 39(2): 521 - 522. [Full Text] [PDF]

				M. Fisher, D. C. Hess, and K. Lees Issues Pertaining to the Critiques of the SAINT-I Trial Stroke, November 1, 2007; 38(11): e126 - e127. [Full Text] [PDF]